Stock Research for GRFS

GRFS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

GRFS Stock Chart & Research Data

The GRFS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the GRFS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


GRFS Due diligence Resources & Stock Charts

The GRFS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View GRFS Detailed Price Forecast - CNN Money CNN View GRFS Detailed Summary - Google Finance
Yahoo View GRFS Detailed Summary - Yahoo! Finance Zacks View GRFS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View GRFS Trends & Analysis - Trade-Ideas Barrons View GRFS Major Holders - Barrons
NASDAQ View GRFS Call Transcripts - NASDAQ Seeking View GRFS Breaking News & Analysis - Seeking Alpha
Spotlight View GRFS Annual Report - CompanySpotlight.com OTC Report View GRFS OTC Short Report - OTCShortReport.com
TradeKing View GRFS Fundamentals - TradeKing Charts View GRFS SEC Filings - Bar Chart
WSJ View Historical Prices for GRFS - The WSJ Morningstar View Performance/Total Return for GRFS - Morningstar
MarketWatch View the Analyst Estimates for GRFS - MarketWatch CNBC View the Earnings History for GRFS - CNBC
StockMarketWatch View the GRFS Earnings - StockMarketWatch MacroAxis View GRFS Buy or Sell Recommendations - MacroAxis
Bullish View the GRFS Bullish Patterns - American Bulls Short Pains View GRFS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View GRFS Stock Mentions - StockTwits PennyStocks View GRFS Stock Mentions - PennyStockTweets
Twitter View GRFS Stock Mentions - Twitter Invest Hub View GRFS Investment Forum News - Investor Hub
Yahoo View GRFS Stock Mentions - Yahoo! Message Board Seeking Alpha View GRFS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for GRFS - SECform4.com Insider Cow View Insider Transactions for GRFS - Insider Cow
CNBC View GRFS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for GRFS - OTC Markets
Yahoo View Insider Transactions for GRFS - Yahoo! Finance NASDAQ View Institutional Holdings for GRFS - NASDAQ


Stock Charts

FinViz View GRFS Stock Insight & Charts - FinViz.com StockCharts View GRFS Investment Charts - StockCharts.com
BarChart View GRFS Stock Overview & Charts - BarChart Trading View View GRFS User Generated Charts - Trading View




Latest Financial News for GRFS


Spain's Grifols, China's Shanghai RAAS form strategic alliance
Posted on Thursday March 07, 2019

Spanish blood products company Grifols said on Thursday it has signed a strategic alliance with Shanghai RAAS as it looks to increase its sales of plasma-derived products in China. Under the agreement, the Catalan company will take a 26.2 percent stake in Shanghai RAAS in exchange for a stake of 45 percent (with 40 percent voting rights) in its U.S. division Grifols Diagnostic Solutions (GDS). Grifols said that no external financing was required to fund the transaction which is expected to close in the second half of 2019 pending regulatory approval.


Blood Giant Grifols Acquires $1.9 Billion Stake in Shanghai RAAS
Posted on Thursday March 07, 2019

The Barcelona-based company will acquire a 26 percent stake in Shanghai RAAS in a noncash deal, making it the second-largest shareholder in the Chinese producer, Grifols said in a regulatory filing Thursday. Demand is climbing in China for human serum albumin, a blood-plasma derivative used to treat liver diseases, with supplies limited by strict rules governing blood donation. As part of the deal, Grifols, the world’s largest manufacturer of immunoglobulin, will provide technology and know-how to Shanghai RAAS, as well as engineering services in exchange for fees.


Rigel Pharmaceuticals (RIGL) Q4 2018 Earnings Conference Call Transcript
Posted on Friday March 01, 2019

RIGL earnings call for the period ending December 31, 2018.


Grifols PharmacyKeeper Receives KLAS Category Leader Award for Third Consecutive Year
Posted on Thursday February 21, 2019

This marks the third consecutive year the PharmacyKeeper Verification software has been recognized as the leader in the IV Workflow Management category by KLAS Research, a healthcare IT data and insight-gathering company that collects and publishes impartial research on the software and services used by healthcare providers and payers worldwide. The PharmacyKeeper suite of software applications was developed by MedKeeper, which was acquired by Grifols in January, 2018.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.